The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Clinical trial NCT03304288 · UNKNOWN
Trial details
- NCT number
- NCT03304288
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-11
- Primary completion
- 2021-01-15
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.